Results 211 to 220 of about 208,651 (377)

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance

The Prostate, Volume 85, Issue 12, Page 1104-1113, September 2025.
ABSTRACT Background An accurate estimation of progression risk in patients with prostate cancer (PCa) amenable to active surveillance (AS) is still an unmet need. Among available biomarkers, we considered Prolaris cell‐cycle progression (CCP) test, “triple hit” phenotype (ERG overexpression, PTEN and prostein expression loss) and elevated expression ...
Marco Oderda, Giulia Orlando, Giorgio Calleris, Giulia Capella, Luisa Delsedime, Eleonora Duregon, Paola Francia di Celle, Donatella Pacchioni, Ian Marc Bonapace, Zaibunnisa Zaibunnisa, Daniele D'Agate, Gabriele Montefusco, Claudia Filippini, Mauro Papotti, Paolo Gontero   +14 more
wiley   +1 more source

Listeria Monocytogenes Meningitis After Prostatectomy [PDF]

, 1964
P. G. Richards
openalex   +1 more source

Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active Surveillance

The Prostate, Volume 85, Issue 12, Page 1114-1120, September 2025.
ABSTRACT Background Genomic biomarkers offer opportunities to improve risk stratification for patients with prostate cancer. We performed a transcriptomic profile of active surveillance (AS)‐eligible patients who underwent radical prostatectomy (RP) to understand genomic associations with adverse pathologic features (APF) at RP.
Jamie Michael, Eric V. Li, Mitch Huang, Nicole Handa, Nalin Kundu, Austin Ho, Hiten D. Patel, James A. Proudfoot, Sai Kaushik Shankar Ramesh Kumar, Edward M. Schaeffer, Elai Davicioni, Ridwan Alam, Ashley E. Ross   +12 more
wiley   +1 more source

Corrigendum: Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer

Frontiers in Oncology
Won Sik Ham, Jee Soo Park, Won Sik Jang, Jongchan Kim, Jongchan Kim   +4 more
doaj   +1 more source

PROSTATECTOMY

Annals of Surgery, 1917
openaire   +3 more sources

THE SEQUELAE OF PROSTATECTOMY [PDF]

BMJ, 1932
openaire   +3 more sources

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy

The Prostate, Volume 85, Issue 13, Page 1181-1188, September 15, 2025.
ABSTRACT Background Despite advances in radiotherapy planning, some long‐term prostate cancer survivors experience persistent symptoms. Although overall quality of life appears comparable between patients treated with definitive and salvage radiotherapy and aligns with normative data, prostate‐specific deficits—particularly bowel symptoms—may persist ...
Isabella Gruber, Oliver Koelbl, Maria M. Meier   +2 more
wiley   +1 more source

Frusemide and prostatectomy [PDF]

Journal of British Surgery, 1969
openaire   +2 more sources

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer

The Prostate, Volume 85, Issue 13, Page 1196-1207, September 15, 2025.
ABSTRACT Background Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer responsible for an estimated 20%–30% of castration‐resistant prostate cancer (CRPC) deaths. While NEPC can arise spontaneously, the majority of these cases emerge as treatment‐induced NEPC (tNEPC).
Hye Seung Nam, Andrew Michael Asberry, Xuehong Deng, Sheng Liu, Jiaoti Huang, Chang‐Deng Hu, Jun Wan, Michael K. Wendt   +7 more
wiley   +1 more source

A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era. [PDF]

BJUI Compass
Ward J, Armstrong K, Kang TM, Tham J, Lin YH, Cheng M, Grummet J, Lawrentschuk N, Perera M, Sengupta S, Chang D, Ng M, Bensley J, Steeper M, Krishnaprasad K, Johnson M, Zeps N, Millar J, Ong WL.   +18 more
europepmc   +1 more source